湖岸生物发布2025上半财年未经审计财务业绩，并更新全年财务指引

PR Newswire12/20 11:05

LakeShore Biopharma Sees FY25 Revenues To Be Between RMB 665 Million - RMB 700 Million, Indicating Growth Of 16%-22% YoY

Benzinga12/19 22:24

LakeShore Biopharma H1 2025 EPS $0.02; Revenue $53.08M

Benzinga12/19 22:23

Press Release: LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

Dow Jones12/19 22:05

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga12/17 05:05

Reported Earlier, LakeShore Biopharma Takes Decisive Action In Response To Criminal Allegations Against Former Chairman, Yi Zhang

Benzinga12/13 15:14